Company Therapeutic Solutions International, Inc. Other OTC

Equities

TSOI

US8833781011

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Medical Devices & Implants

Therapeutic Solutions International, Inc. is focused on immune modulation for the treatment of several specific diseases. The Company is developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, and traumatic brain injury (TBI), and for daily health. Its flagship product, QuadraMune, is a multi-patented synergistic blend of pterostilbene, sulforaphane, epigallocatechin gallate, and thymoquinone. Its synergistic blend of ingredients helps the immune system fight off common and complex ailments and promotes healthy T Cell activity. It has developed an allogenic version of StemVacs and has filed patents to cover activating universal donor immune system cells called dendritic cells in a manner so that upon injection they reprogram the body's natural killer (NK) cells. It has obtained exclusive rights to a patented adult stem cell for development of therapeutics in the area of chronic traumatic encephalopathy (CTE), TBI, and lung pathology.

USD in Million	2022	Weight	2023	Weight	Delta
Immune Modulation 100.0 %	0	100.0 %	0	100.0 %	-52.12%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	0	100.0 %	0	100.0 %	-52.12%

Managers	Title	Age	Since
Timothy Dixon CEO	Chief Executive Officer	66	30/03/11
James Veltmeyer CTO	Chief Tech/Sci/R&D Officer	59	17/06/18
Feng Lin CTO	Chief Tech/Sci/R&D Officer	54	02/09/19
Famela Ramos PRN	Corporate Officer/Principal	48	-
Serena Robella SAM	Sales & Marketing	-	11/10/20

Members of the board	Title	Age	Since
Thomas Ichim BRD	Director/Board Member	49	21/01/16
Timothy Dixon CEO	Chief Executive Officer	66	30/03/11

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	4,230,116,869	3,318,983,291 ( 78.46 %)	0	78.46 %

Name	Equities	%	Valuation
Timothy Dixon 9.736 %	411,850,245	9.736 %	411 850 $
John Peck 5.373 %	227,283,333	5.373 %	227 283 $
Thomas Ichim 3.948 %	167,000,000	3.948 %	167 000 $
Jadi Cell LLC 3.106 %	131,402,390	3.106 %	131 402 $
Feng Lin 1.466 %	62,000,000	1.466 %	62 000 $
James Veltmeyer 0.8747 %	37,000,000	0.8747 %	37 000 $
Famela Ramos 0.1418 %	6,000,000	0.1418 %	6 000 $
Strategic Investment Solutions, Inc. (Illinois) 0.000071 %	3,000	0.000071 %	3 $

Therapeutic Solutions International, Inc.

701 Wild Rose Lane

83525, Elk

http://www.therapeuticsolutionsint.com

address Therapeutic Solutions International, Inc.(TSOI)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Devices & Implants

	1st Jan change	Capi.
STRYKER CORPORATION	+11.10%	127B
SMITH & NEPHEW PLC	-5.10%	11.32B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+4.02%	9.04B
GLAUKOS CORPORATION	+37.26%	5.56B
INSPIRE MEDICAL SYSTEMS, INC.	-24.34%	4.72B
AXONICS, INC.	+8.58%	3.45B
ENOVIS CORPORATION	-6.73%	2.86B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-5.85%	2.07B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-11.84%	2.04B

Medical Devices & Implants